Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Profile of Magaldrate (Gastrofast Advance) in Healthy Women
NCT06367452Phase 4Completed
- Sponsor
- Tecnoquímicas S.A.
- Start
- Oct 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of magaldrate in gastroesophageal reflux disease (GERD), sponsored by Tecnoquímicas S.A.. Started Oct 2023; status: completed.
02
Drugs
magaldrate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT06367452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06367452.